62023TJ0512_INF
Judgment of the General Court (Second Chamber) of 15 May 2024 –Cellphenomics v EUIPO (CellCompDx)
(Case T‑512/23) (
1
)
(EU trade mark – Application for EU word mark CellCompDx – Absolute ground for refusal – Descriptive character – Article 7(1)(c) of Regulation (EU) 2017/1001)
1.
EU trade mark – Definition and acquisition of the EU trade mark – Absolute grounds for refusal – Marks consisting exclusively of signs or indications which may serve to designate the characteristics of a product or service – Assessment of the descriptive character of a sign – Criteria
(European Parliament and Council Regulation 2017/1001, Art. 7(1)(c))
(see paragraphs 13-15, 20, 29, 30, 46)
2.
EU trade mark – Definition and acquisition of the EU trade mark – Absolute grounds for refusal – Marks consisting exclusively of signs or indications which may serve to designate the characteristics of a product or service – Word mark CellCompDx
(European Parliament and Council Regulation 2017/1001, Art. 7(1)(c))
(see paragraphs 21, 27, 31, 34, 35, 39, 42)
3.
EU trade mark – Definition and acquisition of the EU trade mark – Assessment of the registrability of a sign – EU rules only taken into account – Decisions of national authorities not binding on EU bodies
(European Parliament and Council Regulation 2017/1001)
(see paragraph 25)
Operative part
The Court:
1.
Dismisses the action;
2.
Orders each party to bear its own costs.
(
1
)	OJ C 36, 9.10.2023